Chemometric-assisted UV-Vis spectrophotometric method for the simultaneous quantification of triple anthelmintics in vet

Drugs & Regulation

UV-Vis method quantifies triple anthelmintics in veterinary drugs

Veterinary pharmaceutical laboratories can resolve three anthelmintic compounds in a finished drug product through a single UV-Vis spectrophotometric reading, according to a Nature-portfolio paper applying chemometric data processing.

Photo: AI-generated

A single spectrophotometric reading, processed through multivariate mathematics, separates and quantifies three anthelmintic compounds in a finished veterinary pharmaceutical product — a workflow described in a paper indexed to the Nature publishing portfolio.

What does the method change?

Quality-control laboratories producing or regulating combination dewormers face a recurring decision: run three separate assays on three separate instruments, or accept a less specific single-screen test. The published workflow proposes a third path — one inexpensive UV-Vis scan analyzed by chemometric software to resolve the three actives' concentrations simultaneously.

Combination dewormers — fixed-dose products that pair two or more anthelmintics in a single tablet, drench, or injectable — form the backbone of parasite-control programs in livestock and a large share of canine and feline parasite prophylaxis. Validating each component's potency has historically demanded three separate analytical runs, multiplying instrument time and consumable cost per batch.

In livestock, classic triples combine a macrocyclic lactone such as ivermectin with a benzimidazole such as fenbendazole and an imidazothiazole such as levamisole; in companion-animal products, praziquantel often joins ivermectin and a benzimidazole for tapeworm coverage.

How does it work?

UV-Vis spectrophotometry measures how a dissolved drug absorbs ultraviolet and visible light at characteristic wavelengths. When three compounds absorb in overlapping regions, a raw scan cannot distinguish them.

Chemometric tools — mathematical models such as partial least-squares regression or principal component regression — extract each compound's signal from the mixture. The paper's design trains the algorithm against spectra of the three target anthelmintics at known concentrations, then applies the trained model to unknown formulations to back-calculate each active's weight percentage.

What changes at the bench and in the barn?

The study design reported no in-clinic deployment; the assay is a pharmaceutical-release tool, not a clinical diagnostic. Its downstream effect reaches veterinary practice through supply economics rather than direct sample testing.

  • Food-animal practice stands to benefit most directly. Combination dewormers dominate parasite-control programs in cattle, sheep, and goats, where triple-active products address gastrointestinal nematodes, lungworms, and tapeworms in one dose. Faster batch release compresses the manufacturing timeline for those products, which clear regulatory review under FDA Center for Veterinary Medicine, EMA, and USDA pathways before reaching producers.
  • Companion-animal practice receives the same supply effect for canine and feline combination tablets, where triple-active dewormers serve as routine maintenance prescriptions. A shorter release cycle shortens distributor lead time on the most-prescribed parasite preventives.
  • Public-health and food-safety laboratories monitoring residue programs can apply the same single-instrument workflow to finished-product screening, reducing the analytical footprint of batch verification at abattoir-adjacent and import-testing facilities.

What limitations remain?

The headline announcement alone does not disclose the specific three anthelmintics covered, the limits of quantification, or the comparative accuracy against the HPLC reference methods that regulators currently accept for release certification.

Chemometric assays require carefully constructed calibration sets; a poorly designed training set produces biased readings, and the paper's full text will determine whether the method withstands validation standards the United States Pharmacopoeia, the European Pharmacopoeia, and FDA, EMA, and USDA reviewers apply.

The technique also inherits the standard UV-Vis constraint: it cannot resolve trace impurities below approximately 0.1 percent without composition-specific method extension.

What comes next?

Inter-laboratory validation paired with head-to-head HPLC comparison will determine whether the chemometric UV-Vis workflow enters the routine release-certification toolbox in the next regulatory review cycle.

Source: Google News: Veterinary drugs

Share this article:

Nathan Brooks

Show full bio

Senior reporter covering companies, deals and strategy in Small- and large-animal clinical practice at The Vet Scope.

More from Nathan Brooks →